EchoGo® Heart Failure vs CAC Software
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, EchoGo® Heart Failure, is designed for the detection of Heart Failure with preserved Ejection Fraction (HFpEF) through the analysis of echocardiograms. In contrast, Tool B, CAC Software, focuses on quantifying coronary artery calcification from non-contrast chest CT scans to assess coronary artery disease risk. While both are AI-powered cardiology tools, they address different cardiac conditions and utilize distinct imaging modalities, making them complementary rather than direct competitors.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Ultromics' EchoGou00ae Heart Failure is an AI platform designed to detect Heart Failure with preserved Ejection Fraction (HFpEF) by analyzing routine echocardiograms. Imbio's CAC Software helps radiologists and cardiologists determine the location and calculate the amount of calcification within the coronary arteries, supporting risk assessment for coronary artery disease.
EchoGou00ae Heart Failure analyzes routine echocardiogram video clips. Imbio's Coronary Artery Calcification (CAC) software performs analysis on non-contrast, chest computed tomography (CT) scans.
EchoGou00ae Heart Failure provides insights for HFpEF detection within 20 minutes, with clinically validated 90% sensitivity and 86% specificity. Imbio's CAC Software outputs the Agatston score, arterial age, calcified lesion mass, and volume, along with 3D visualizations and annotated images.
EchoGou00ae Heart Failure offers seamless integration with existing workflows and IT stacks, utilizing a DICOM workflow for report delivery to PACS. Imbio's CAC Software integrates into existing DICOM viewing workflows.
EchoGou00ae Heart Failure is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis, and is covered by Medicare and select commercial insurers. For Imbio's CAC Software, pricing information requires direct contact with the company.